Innova Biosciences, Cambridge, UK, has launched a europium bead conjugation kit, the latest addition to its range of particle technologies. Europium conjugates provide much higher sensitivity when compared with other particles commonly used in point-of-care diagnostics. However, europium beads are known to be difficult to handle. The new kit facilitates the generation of highly stable europium conjugates, often allowing 10- to 100-fold improved limits of detection compared with other common particles, without the need for complex conjugation procedures or extensive technical knowledge. The europium beads included in the new kit have a specially treated surface that covalently binds antibodies and proteins, generating highly stable conjugates that are resistant to aggregation. Antibody-europium bead conjugates generated using Innova Biosciences’ unique technology can be used in either immunochromatographic lateral-flow tests or microplate-based assays. For more information, visit Innova Biosciences.